Healthcare · NSE: GLAND
Gland Pharma Limited
₹3,049.00
+3.00% · close 28 Oct 2026
52-week range
₹1,596.80 – ₹3,150.60
From 52W high
-3.22%
Return 1Y
+60.27%
Volume · Avg 20D
2.83 L · 4.29 L
Returns & technicals
1W+3.88%
1M+4.52%
3M+25.56%
6M+71.73%
1Y+60.27%
| 50-day average | ₹2,933.95 above |
| 200-day average | ₹2,260.49 above |
| Volatility (1Y, annualised) | 33.81% |
| RSI (14) | 57.0 |
| MACD histogram (12, 26, 9) | -12.59 |
| Delivery · 20D avg | 45.66% · 54.07% |
| Turnover (last day) | ₹85 Cr |
Profile
| Symbol | GLAND |
| ISIN | INE068V01023 |
| Sector | Healthcare |
| Listed on NSE | 20 Nov 2020 |
| Face value | ₹1 |
| Series | EQ |
Financials & shareholding
Quarterly results, P/E and the shareholding pattern for GLAND are coming in a later update.
Peers in Healthcare
| Stock | Price | Day | 1M | 1Y |
|---|---|---|---|---|
| PPLPHARMA Piramal Pharma Limited | ₹232.80 | +17.15% | +10.69% | +15.19% |
| SYNGENE Syngene International Limited | ₹410.85 | +12.19% | +8.49% | -37.51% |
| ACUTAAS Acutaas Chemicals Limited | ₹3,710.00 | -2.20% | +13.37% | +116.38% |
| DIVISLAB Divi's Laboratories Limited | ₹9,558.50 | +0.56% | -0.63% | +48.46% |
| ONESOURCE Onesource Specialty Pharma Limited | ₹1,577.60 | -0.77% | -1.56% | -14.00% |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137.00 | +4.43% | -8.46% | +3.25% |